Simplex Trading
LEGN icon

Simplex Trading’s Legend Biotech LEGN Stock Holding History

Simplex Trading’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$898K Sell
31,100
-37,500
-55% -$1.01M ﹤0.01% 2906
2026
Q1 		$1.24M Buy
68,600
+56,700
+476% +$1.08M ﹤0.01% 2278
2025
Q4 		$259K Sell
11,900
-25,300
-68% -$725K ﹤0.01% 3966
2025
Q3 		$1.21M Sell
37,200
-11,000
-23% -$406K ﹤0.01% 2851
2025
Q2 		$1.71M Buy
48,200
+34,000
+239% +$1.1M ﹤0.01% 2250
2025
Q1 		$481K Buy
14,200
+10,900
+330% +$391K ﹤0.01% 3446
2024
Q4 		$107K Sell
3,300
-1,700
-34% -$70.4K ﹤0.01% 5109
2024
Q3 		$243K Sell
5,000
-8,100
-62% -$431K ﹤0.01% 4326
2024
Q2 		$580K Sell
13,100
-34,800
-73% -$1.61M ﹤0.01% 3506
2024
Q1 		$2.69M Sell
47,900
-3,000
-6% -$181K ﹤0.01% 2119
2023
Q4 		$3.06M Buy
50,900
+38,400
+307% +$2.43M ﹤0.01% 1989
2023
Q3 		$839K Sell
12,500
-13,700
-52% -$952K ﹤0.01% 2853
2023
Q2 		$1.81M Sell
26,200
-3,800
-13% -$248K ﹤0.01% 2043
2023
Q1 		$1.45M Sell
30,000
-8,900
-23% -$435K ﹤0.01% 2235
2022
Q4 		$1.94M Sell
38,900
-19,200
-33% -$930K ﹤0.01% 1888
2022
Q3 		$2.37M Sell
58,100
-800
-1% -$37.5K ﹤0.01% 1803
2022
Q2 		$3.24M Buy
58,900
+50,800
+627% +$2.15M ﹤0.01% 1433
2022
Q1 		$294K Buy
8,100
+6,500
+406% +$257K ﹤0.01% 4583
2021
Q4 		$74K Buy
1,600
+1,400
+700% +$71K ﹤0.01% 6697
2021
Q3 		$8K Hold
200
– – ﹤0.01% 9050
2021
Q2 		$8K Buy
200
+198
+9,900% +$6.73K ﹤0.01% 9220
2021
Q1 		$5K Buy
+2
New +$55 ﹤0.01% 8210

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Simplex Trading's LEGN Position: Q2 2026 in Review

Simplex Trading opened a new position in Legend Biotech (LEGN) in Q2 2026: 2,907 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #5766 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LEGN as recently as Q4 2025.

Simplex Trading first reported a position in LEGN in Q1 2021 and has held it in 11 quarters since. The position peaked at $640K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Simplex Trading held 2,907 shares of Legend Biotech worth $84K as of Q2 2026.
  • Legend Biotech was a new Simplex Trading position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5766 holding.
  • Simplex Trading first reported a position in Legend Biotech in Q1 2021 and has held it in 11 quarters since.
  • Simplex Trading's Legend Biotech position peaked at $640K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.